FELL DONALD G. sold 50.0% of their position (20K shares) of ASPIRE BIOPHARMA HOLDINGS, INC. on the open market
Open‑market sale worth $7.8K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 6/6/2025ACC: 0001641172-25-014102
Director
Since Aug 2023
-20K
Net shares
Net seller
$7.8K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
20K disposed
Non-Derivative Transactions2
Common Stock, par value $0.0001
Direct
Shares
−9.50K
Price / share
$0.39
Trade value
$3.71K
% of position
50.0%
6/4/2025
19K→9.50K
Common Stock, par value $0.0001
Direct
Shares
−10.50K
Price / share
$0.39
Trade value
$4.09K
% of position
34.4%
6/5/2025
30.50K→20K
Total
Net shares
−20K
Net value
-$7.80K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.0001 Direct | 6/4/2025 | P · Purchase | −9.50K | $0.39 | $3.71K | 50.0% | 19K | 9.50K |
| Common Stock, par value $0.0001 Direct | 6/5/2025 | P · Purchase | −10.50K | $0.39 | $4.09K | 34.4% | 30.50K | 20K |
| Total | −20K | -$7.80K | ||||||
Derivative Transactions0
No derivative transactions reported